Abstract
The aim of this study was to evaluate the efficacy of multimodality treatment of glioblastoma multiforme in the elderly. Although several studies report a poor outcome in elderly patients with glioblastoma, in the light of our experience, treatment of elderly patients with glioblastoma in non-critical areas and Karnofsky Performance Status > 60 should be just as aggressive as in younger patients.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Brain Neoplasms / drug therapy
-
Brain Neoplasms / radiotherapy
-
Brain Neoplasms / surgery
-
Brain Neoplasms / therapy*
-
Dacarbazine / analogs & derivatives*
-
Dacarbazine / therapeutic use
-
Female
-
Glioblastoma / drug therapy
-
Glioblastoma / radiotherapy
-
Glioblastoma / surgery
-
Glioblastoma / therapy*
-
Humans
-
Male
-
Neoplasm Recurrence, Local
-
Neoplasm, Residual
-
Survival Rate
-
Temozolomide